Alkem Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)
Alkem Laboratories Ltd · Outcome · 12 Nov 2026, 7:20 pm
Alkem Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 45,520 (+13.8% YoY | +21.7% QoQ) ■ EBITDA: 10,252 (+11.3% YoY | +33.8% QoQ) ■ EBITDA Margin (%): 22.5 (-49 bps YoY | +204 bps QoQ) ■ PAT: 6,753 (-11.7% YoY | +29.9% QoQ) ■ EPS (INR): 56.5 (-11.7% YoY | +29.9% QoQ) Alkem Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) Segmental Performance Pharmaceuticals ■ Revenue: 43,479 (+11.8% YoY | +19.0% QoQ) ■ EBIT: 10,519 (+26.3% YoY | +36.7% QoQ) ■ EBIT Margin (%): 24.2 (+278 bps YoY | +313 bps QoQ) Biotech ■ Revenue: 1,298 (-18.0% YoY | +8.3% QoQ) ■ EBIT: -1,141 (Profit to Loss YoY | -25.0% QoQ) ■ EBIT Margin (%): -87.9 (Profit to Loss YoY | -1179 bps QoQ) MedTech ■ Revenue: 1,331 (+4831.1% YoY | +1640.4% QoQ) ■ EBIT: -496 (-686.5% YoY | -305.1% QoQ) ■ EBIT Margin (%): -37.3 (+19643 bps YoY | +12285 bps QoQ)
Original exchange filing (PDF)
More announcements from Alkem Laboratories Ltd
- Please find attached herewith Q2 H1FY2027 - Earnings Conference Call Transcript · 18 Nov 2026
- With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the '' Q2 and H1FY27 Earnings Conference Call'' .... · 13 Nov 2026
- We wish to inform you that the Company has appointed Mr. Gopal Kothari as the CFO and KMP of the Company wef 2nd Dec, 2026. · 12 Nov 2026
- Pl find enclosed press release and analyst presentation on Q2 and H1FY27 earnings and business updates of the Company · 12 Nov 2026
- Pl find enclosed unaudited financial results along with Limited Review Report of the Company for quarter and half year ended 30th Sept, 2026. · 12 Nov 2026
- Alkem Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 12 Nov 2026
- Please find attached herewith intimation of incorporation of subsidiary in the form of Joint Venture. · 09 Nov 2026
- With reference to your email regarding the captioned corporate announcement submitted by the Company on 03rd November, 2026 under Regulation 30 of the SEBI (Listing Obligations and Disclosure .... · 05 Nov 2026
